Abstract:To realize the therapeutic potential of gene drugs for Alzheimer's disease (AD), non-invasive, tissue specific and efficient delivery technologies must be developed. Here, a hybrid system for amyloid plaques targeted siRNA delivery was formed by PEGylated Poly(2-(N,N-dimethylamino) ethyl methacrylate) (PEG-PDMAEMA) conjugated with two d-peptides, a CGN for brain penetration and a QSH for beta-amyloid binding. The hybrid complex CQ/siRNA, composed of 25% MPEG-PDMAEMA, 50% CGN-PEG-PDMAEMA and 25% QSH-PEG-PDMAEMA, showed negligible cytotoxicity and could protect siRNA from enzyme degradation. Being taken up by neuron cells, the complexes could escape from lysosomes, release siRNA in the cytoplasm and thus producing effective gene silence (down-regulated protein level to 18.5%). After intravenous injection, CQ/siRNA penetrated into the brain in an intact form and located around the plaques in transgenic AD mice. The precisely amyloid plaques delivery resulted in increased therapeutic activities, which was demonstrated by the strong mRNA (36.4%) knockdown of BACE1 (a therapeutic target of AD), the less yield of enzyme-digested products sAPP beta (-42.6%), as well as the better neurons protection than the single component complexes. In conclusion, the hybrid complex could efficiently and precisely deliver an siRNA to the AD lesion and might be a potential candidate for gene therapy for AD.Statement of SignificanceThe gene delivery system achieving high brain penetration and lesion region accumulation was first applied to treat AD, and the preparation exhibited a significantly better neuroprotective effect than that modified with a single ligand. The intracellular process of which the complexes escape from lysosomes and release the siRNA in cytoplasm was revealed. The brain targeting and amyloid plaque binding ability of the complex were systemic evaluated, and the in vivo co-location experiments provided a direct evidence of the precise delivery of the siRNA to the amyloid plaques. One of the targeting ligands, CGN, which was a retro-inverso modified peptide to achieve better affinity to the BBB, was first applied to the brain targeting system. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

TaqTth-hpRNA: a Novel Compact RNA-targeting Tool for Specific Silencing of Pathogenic Mrna

Induction of silencing effect of Alzheimer disease familial Swedish mutant APP by RNA interference

Induction of Silencing Effect of Swedish Mutant Amyloid Precursor Protein by RNA Interference

TALEN/CRISPR-mediated Engineering of a Promoterless Anti-Viral RNAi Hairpin into an Endogenous Mirna Locus

Allele-specific Silencing of Dominant Disease Genes.

207. Micro RNAs as Novel siRNA Shuttles

Effective and Accurate Gene Silencing by a Recombinant AAV-Compatible MicroRNA Scaffold.

Targeting Β-Secretase with RNAi in Neural Stem Cells for Alzheimer's Disease Therapy.

Crab-shaped DNA Tetrahedral Nanomachine for Silencing Undruggable Mrna Targets in Prostate Cancer

In vivo self-assembled small RNAs as a new generation of RNAi therapeutics

Small Interfering RNA Delivery to the Neurons Near the Amyloid Plaques for Improved Treatment of Alzheimer׳s Disease

Sequencing-Guided Design of Genetically Encoded Small RNAs Targeting CAG Repeats for Selective Inhibition of Mutant Huntingtin

Enhanced Target Gene Knockdown by a Bifunctional Shrna: a Novel Approach of RNA Interference

A Hybrid Sirna Delivery Complex for Enhanced Brain Penetration and Precise Amyloid Plaque Targeting in Alzheimer's Disease Mice.

Artificial Small RNA for Sequence Specific Cleavage of Target RNA Through RNase III Endonuclease Dicer

Short RNA chaperones promote aggregation-resistant TDP-43 conformers to mitigate neurodegeneration

Polymeric RNAi Constructs Tailored with Appreciable Transcellular Trafficking Functions for Potential Suppression of Parathyroid Hormone Production

Therapeutic Reversal of Huntington’s Disease by in Vivo Self-Assembled Sirnas

Profiling of Mismatch Discrimination in RNAi Enabled Rational Design of Allele-Specific Sirnas

siRNA-mediated gene silencing in vitro and in vivo

Targeted pre-mRNA modification for gene silencing and regulation